KR20230008159A - 호흡기 장애의 치료를 위한 줄기세포 - Google Patents

호흡기 장애의 치료를 위한 줄기세포 Download PDF

Info

Publication number
KR20230008159A
KR20230008159A KR1020227042331A KR20227042331A KR20230008159A KR 20230008159 A KR20230008159 A KR 20230008159A KR 1020227042331 A KR1020227042331 A KR 1020227042331A KR 20227042331 A KR20227042331 A KR 20227042331A KR 20230008159 A KR20230008159 A KR 20230008159A
Authority
KR
South Korea
Prior art keywords
composition
mscs
use according
disease
integrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020227042331A
Other languages
English (en)
Korean (ko)
Inventor
아커룬드 에비 룬드그렌
산드라 린드스테드
크리스티나 우베브란트
모레노 타니아 라모스
Original Assignee
신텔라 에이비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 신텔라 에이비 filed Critical 신텔라 에이비
Publication of KR20230008159A publication Critical patent/KR20230008159A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transplantation (AREA)
KR1020227042331A 2020-05-07 2021-05-07 호흡기 장애의 치료를 위한 줄기세포 Pending KR20230008159A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20173592 2020-05-07
EP20173592.5 2020-05-07
PCT/EP2021/062111 WO2021224449A1 (en) 2020-05-07 2021-05-07 Stem cells for treatment of respiratory disorders

Publications (1)

Publication Number Publication Date
KR20230008159A true KR20230008159A (ko) 2023-01-13

Family

ID=70738255

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227042331A Pending KR20230008159A (ko) 2020-05-07 2021-05-07 호흡기 장애의 치료를 위한 줄기세포

Country Status (11)

Country Link
US (1) US20230346843A1 (https=)
EP (1) EP4146234A1 (https=)
JP (1) JP7821414B2 (https=)
KR (1) KR20230008159A (https=)
CN (1) CN116018149A (https=)
AU (1) AU2021266603A1 (https=)
BR (1) BR112022022355A2 (https=)
CA (1) CA3177704A1 (https=)
IL (1) IL297902A (https=)
MX (1) MX2022013939A (https=)
WO (1) WO2021224449A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202103890D0 (en) * 2021-03-19 2021-05-05 Amniotics Ab Stem cells for use in reducing the immune response following organ transplantation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007099337A1 (en) * 2006-03-01 2007-09-07 Cartela R&D Ab Expansion and differentiation of mesenchymal stem cells
CN110177560A (zh) * 2016-12-28 2019-08-27 智再如股份有限公司 活体组织损伤的修复剂以及该修复剂的制造方法
ES2870776T3 (es) 2017-01-27 2021-10-27 Xintela Ab Prevención y tratamiento de daños o enfermedades de los huesos y cartílagos
CN116590227A (zh) * 2017-03-03 2023-08-15 日本乐敦制药株式会社 间充质干细胞和肝疾病治疗剂
WO2018159432A1 (ja) * 2017-03-03 2018-09-07 ロート製薬株式会社 間葉系幹細胞及び医薬組成物

Also Published As

Publication number Publication date
CN116018149A (zh) 2023-04-25
BR112022022355A2 (pt) 2022-12-13
JP2023524150A (ja) 2023-06-08
MX2022013939A (es) 2023-02-09
CA3177704A1 (en) 2021-11-11
US20230346843A1 (en) 2023-11-02
JP7821414B2 (ja) 2026-02-27
EP4146234A1 (en) 2023-03-15
WO2021224449A1 (en) 2021-11-11
AU2021266603A1 (en) 2022-12-08
IL297902A (en) 2023-01-01

Similar Documents

Publication Publication Date Title
JP7691488B2 (ja) 肺疾患を治療するための方法及び組成物
JP2020531011A (ja) 精製された間葉系幹細胞エキソソームおよびその使用
JP6666395B2 (ja) 移植のための臓器の改良
JP2009535035A (ja) 肝臓再生における脂肪細胞由来成体幹細胞
CN106659743A (zh) 免疫病症的治疗
EP2624847A2 (en) Human lung stem cells and uses thereof
US20160324898A1 (en) Compositions and methods for the treatment of alzheimer's disease
KR20220164741A (ko) 중간엽 계통 전구세포 또는 줄기세포를 이용한 과염증 치료 방법
US20250268948A1 (en) Compositions and methods for treating post acute sequelae of sars-cov-2 infection (long covid)
KR102464099B1 (ko) 다능성 간세포에 의한 허혈재관류 폐장애의 경감 및 치료
KR20230008159A (ko) 호흡기 장애의 치료를 위한 줄기세포
CN115361958A (zh) 使用间充质谱系前体或干细胞治疗炎症性肺病的方法
US20240207323A1 (en) Method for treating acute respiratory distress syndrome (ards) using mesenchymal lineage precursor or stem cells
WO2014089397A1 (en) Compositions and methods of treating and preventing pulmonary fibrosis
CN117425724A (zh) 肿瘤缺氧驯化的再生巨噬细胞的获得方法及其在再生医学中的用途
US20200054684A1 (en) Non-mesenchymal human lung stem cells and methods of their use for treating respiratory diseases
US20210338740A1 (en) Therapeutic methods and compositions
Ogawa et al. Endobronchial Ultrasound-Guided Pulmonary Arterial Injection of Airway Organoids Enables Peripheral Lung Engraftment in a Porcine Model
WO2017096386A1 (en) Compositions and methods for treating and preventing bleeding and lung injuries and diseases
CN120265758A (zh) 治疗性巨噬细胞
CN101605884A (zh) 肝再生中脂肪衍生的成体干细胞
CN117337184A (zh) 使用间充质谱系前体细胞或干细胞治疗急性呼吸窘迫综合征(ards)的方法
WO2019059245A1 (ja) 肝線維化疾患の予防又は治療剤
Haaften Mesenchymal stem cells protect the lung from oxygen-induced experimental bronchopulmonary dysplasia

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20221201

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application